References
- Morillo-verdugo R, Morillo-lisa R, Espolita-suarez J, Delgado-sanchez O. Evaluation of patient experience with a model of coordinated telematic pharmaceutical care between hospital and rural pharmacies in Spain: a proof of concept. J Multidiscip Healthc. 2023;16:1037–1046. doi:10.2147/JMDH.S406636
- Margusino-Framiñán L, Llamazares CMF, Negro-Vega E, et al. Outpatients’ opinion and experience regarding telepharmacy during the COVID-19 pandemic: the enopex project. J Multidiscip Healthc. 2021;14:3621–3632. doi:10.2147/JMDH.S343528
- Iftinan GN, Wathoni N, Lestari K. Telepharmacy: a potential alternative approach for diabetic patients during the COVID-19 pandemic. J Multidiscip Healthc. 2021;14:2261–2273. doi:10.2147/JMDH.S325645
- Iftinan GN, Elamin KM, Rahayu SA, Lestari K, Wathoni N. Application, benefits, and limitations of telepharmacy for patients with diabetes in the outpatient setting. J Multidiscip Healthc. 2023;16:451–459. doi:10.2147/JMDH.S400734
- Salah H, Alsamani O, ElLithy MH, Abdelghani LS. Pharmaceutical services department strategies and patient perception to maintain healthcare services during COVID-19 crisis. Saudi Pharm J. 2022;30(11):1639–1645. doi:10.1016/j.jsps.2022.09.006